Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
57 hedge funds and large institutions have $19.5M invested in Ampio Pharmaceuticals Inc. in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 7 closing their positions.
31% more call options, than puts
Call options by funds: $515K | Put options by funds: $392K
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
0% more funds holding
Funds holding: 57 → 57 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
37% less capital invested
Capital invested by funds: $31M → $19.5M (-$11.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$396K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$187K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$150K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$112K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$74.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$518K |
| 2 |
Millennium Management
New York
|
-$183K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$166K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$102K |
| 5 |
BCM
Bluefin Capital Management
New York
|
-$84.9K |
AMPE Hedge Fund Activity: Q1 2016 in Review
57 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2016, worth a combined $19.5M — down 37% from $31M a quarter earlier.
Fund positioning in AMPE was balanced in Q1 2016: 7 funds opened new positions, 7 closed out, 11 added to existing stakes and 10 trimmed.
The largest buyer was Bridgeway Capital Management, adding an estimated $396K. The largest seller was Susquehanna International Group, cutting an estimated $518K.
- 57 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $19.5M of Ampio Pharmaceuticals Inc. stock for Q1 2016, down 37% quarter-over-quarter.
- 7 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2016 and 7 closed out, a net change of 0 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q1 2016 was Bridgeway Capital Management, an estimated $396K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q1 2016 was Susquehanna International Group, an estimated $518K sold.
Based on aggregated 13F filings for Q1 2016.